Repositioning Molecules of Chinese Medicine to Targets of SARS-Cov-2 by Deep Learning Method

被引:7
|
作者
Song, Tao [1 ,2 ]
Zhong, Yue [1 ]
Ding, Mao [3 ]
Zhao, Renteng [4 ]
Tian, Qingyu [1 ]
Du, Zhenzhen [1 ]
Liu, Dayan [1 ]
Liu, Jiali [1 ]
Deng, Yufeng [1 ]
机构
[1] China Univ Petr East China, Coll Comp Sci & Technol, Qingdao 266580, Peoples R China
[2] Univ Politecn Madrid, Fac Comp Sci, Dept Artificial Intelligence, Campus Montegancedo, Madrid 28660, Spain
[3] Shandong Univ, Hosp 2, Dept Intens Care Unit, Jinan 250033, Peoples R China
[4] Trinity Earth Technol Co Ltd, Mumbai, Maharashtra, India
基金
中国国家自然科学基金;
关键词
SARS-CoV-2; Chinese medicine; deep convolutional neural network; drug reposition; SYSTEMS;
D O I
10.1109/BIBM49941.2020.9313151
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Traditional Chinese medicine has been used to treat and prevent infectious diseases for thousands of years, and has accumulated a large number of effective prescriptions. Deep learning methods provide powerful applications in calculating interactions between drugs and targets. In this study, we try to use the method of deep learning to reposition molecules of Chinese medicines (CMs) and the targets of syndrome coronavirus 2 (SARS-CoV-2). A deep convolution neural network with residual module (DCNN-Res) is constructed and trained on KIBA dataset. The accuracy of predicting the binding affinity of drug-target pairs is 85.33%. By ranking binding affinity scores of 433 molecules in 35 CMs to 6 targets of SARS-Cov-2, DCNN-Res recommends 30 possible repositioning molecules. The consistency between our result and the latest research is 0.827. The molecules in Gancao and Huangqin have a strong binding affinity to targets of SARS-CoV-2, which is also consistent with the latest research.
引用
收藏
页码:2306 / 2312
页数:7
相关论文
共 50 条
  • [21] SARS-CoV-2 Infectivity and Neurological Targets in the Brain
    Lukiw, Walter J.
    Pogue, Aileen
    Hill, James M.
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2022, 42 (01) : 217 - 224
  • [22] Virtual Screening and Molecular Simulation Uncover Potent Traditional Chinese Medicine Small Molecules Against SARS-CoV-2 Mpro
    Han, Di
    Yang, Hongkun
    Gao, Yunlong
    Xue, Yiwei
    Liu, Fengxiang
    Wang, Meiting
    Lu, Jiarui
    Liu, Taigang
    Xu, Yongtao
    CHEMISTRYSELECT, 2025, 10 (12):
  • [23] Deep learning application detecting SARS-CoV-2 key enzymes inhibitors
    Leila Benarous
    Khedidja Benarous
    Ghulam Muhammad
    Zulfiqar Ali
    Cluster Computing, 2023, 26 : 1169 - 1180
  • [24] Deep learning application detecting SARS-CoV-2 key enzymes inhibitors
    Benarous, Leila
    Benarous, Khedidja
    Muhammad, Ghulam
    Ali, Zulfiqar
    CLUSTER COMPUTING-THE JOURNAL OF NETWORKS SOFTWARE TOOLS AND APPLICATIONS, 2023, 26 (02): : 1169 - 1180
  • [25] SARS-CoV-2 in perioperative medicine: lessons learnt
    Eochagain, Aisling Ni
    Hardman, Jonathan G.
    Buggy, Donal J.
    BRITISH JOURNAL OF ANAESTHESIA, 2021, 126 (05) : E187 - E188
  • [26] Diving and hyperbaric medicine in the SARS-CoV-2 pandemic
    Mitchell, Simon J.
    DIVING AND HYPERBARIC MEDICINE, 2020, 50 (02) : 90 - 91
  • [27] Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2
    Fan, Shiyong
    Xiao, Dian
    Wang, Yanming
    Liu, Lianqi
    Zhou, Xinbo
    Zhong, Wu
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (17) : 1565 - 1578
  • [28] Potential treatment with Chinese and Western medicine targeting NSP14 of SARS-CoV-2
    Liu, Chao
    Zhu, Xiaoxiao
    Lu, Yiyao
    Zhang, Xianqin
    Jia, Xu
    Yang, Tai
    JOURNAL OF PHARMACEUTICAL ANALYSIS, 2021, 11 (03) : 272 - 277
  • [29] Compounds of plants with activity against SARS-CoV-2 targets
    Marmitt, Diorge Jonatas
    Goettert, Marcia Ines
    Rempel, Claudete
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (05) : 623 - 633
  • [30] Potential treatment with Chinese and Western medicine targeting NSP14 of SARS-CoV-2
    Chao Liu
    Xiaoxiao Zhu
    Yiyao Lu
    Xianqin Zhang
    Xu Jia
    Tai Yang
    Journal of Pharmaceutical Analysis, 2021, 11 (03) : 272 - 277